New Delhi: Foodtech platform HealthKart on Monday stated it has raised $135 million in a funding spherical led by Temasek, with participation from A91 Companions and Kae Capital.
The omni-channel vitamin retailer stated the funds raised shall be deployed in the direction of the expansion of in-house direct-to-consumer (D2C) manufacturers, improve offline distribution, broaden worldwide operations and make choose acquisitions.
“Driving health and preventive well being by addressing the dietary gaps is a systemic development which is taking off in a giant means in India. With HealthKart’s R&D capabilities and omni-channel distribution infrastructure, we’re excited to prepared the ground,” stated Sameer Maheshwari, Founder and CEO, HealthKart.
At greater than Rs 1,000 crore annual income run fee, HealthKart has two main manufacturers – MuscleBlaze and HKVitals.
MuscleBlaze now has 25 per cent share of India’s sports activities vitamin market whereas HKVitals has 20 per cent share of on-line well being complement market, the platform claimed.
“It’s a digital-first pioneer which has efficiently transitioned into an omni-channel enterprise, and achieved market management up to now 5 years within the segments it operates in,” stated VT Bharadwaj from A91 Companions.
The corporate stated its merchandise are being utilized by greater than 1,000,000 shoppers each month and are extensively distributed throughout a number of channels — healthkart.com, D2C web sites, offline grocers/chemists, 140+ HealthKart offline shops — in addition to main e-commerce and fast commerce platforms.